Matthew McManus

Chief Operating Officer, Azenta Life Sciences.

Companies

Bio-TechnePresident Feb 5, 2024 to Mar 4, 2026¹
Azenta Life SciencesChief operating officer Feb 2, 2022 to Aug 22, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Azenta Life Sciences AZTA29,467 shares³$1.0M at $35.31Aug 19, 2022
Bio-Techne TECH7,691 shares⁴$557.8K at $72.53Feb 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 1, 2026Shares withheld for tax 1,665 shares at $64.09 of Bio-Techne⁴
Feb 1, 2026Exercised options 4,621 shares of Bio-Techne⁴
Aug 15, 2025Shares withheld for tax 880 shares at $53.60 of Bio-Techne⁵
Aug 15, 2025Exercised options 2,637 shares of Bio-Techne⁵
Feb 1, 2025Shares withheld for tax 1,642 shares at $73.55 of Bio-Techne⁶
Feb 1, 2025Exercised options 4,620 shares of Bio-Techne⁶
Aug 19, 2022Bought 8,625 shares at $58.15 of Azenta Life Sciences³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBio-Techne, President
2
SEC EDGARAzenta Life Sciences, Chief operating officer
3
SEC EDGARAzenta Life Sciences shares after the filing of Aug 19, 2022
4
SEC EDGARBio-Techne shares after the filing of Feb 1, 2026
5
SEC EDGARForm 4 filed Aug 19, 2025
6
SEC EDGARForm 4 filed Feb 4, 2025